Rachael Sarpong
Society of Interventional Radiology, University of Sheffield, Age UK
Papers
5
Total Citations
464
H-Index
5
About
Dr. Rachael Sarpong is a pioneering urologic surgeon and researcher whose work is transforming the surgical management of bladder cancer. Her primary research focuses on comparing robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion to the traditional open approach, aiming to improve patient recovery and reduce morbidity. Dr. Sarpong’s landmark 2022 study, published in a top-tier journal with over 320 citations, provided pivotal evidence that total intracorporeal robotic surgery can significantly enhance 90-day recovery outcomes without compromising safety. She also led the protocol for the influential iROC randomized controlled trial (88 citations), which established a rigorous framework for comparing these techniques. Demonstrating a keen interest in healthcare value, her 2023 cost-effectiveness analysis (26 citations) clarified the economic benefits of the robotic approach for payers. Additionally, Dr. Sarpong has innovatively explored the use of wearable devices and cardiopulmonary exercise testing to predict postoperative complications, showcasing her commitment to personalized, data-driven preoperative assessment. Her work is not only advancing surgical technique but also redefining the standards of recovery and value in bladder cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5